Number of items: 9.
2025
    Haddad, T. S. et al.
  
(2025)
  
Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosis.
    
    Scientific Reports, 15(1),
	 
      16944.
    
    (doi: 10.1038/s41598-025-00866-x)
    (PMID:40374662) 
    (PMCID:PMC12081641) 
  
  
2024
    Pennel, K. A.F. et al.
  
(2024)
  
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
    
    Journal of Experimental and Clinical Cancer Research, 43,
	 
      64.
    
    (doi: 10.1186/s13046-024-02958-4)
    (PMID:38424636) 
    (PMCID:PMC10905886) 
  
  
2023
    Haddad, T. S. et al.
  
(2023)
  
Pseudobudding: ruptured glands do not represent true tumor buds.
    
    Journal of Pathology, 261(1),
	  pp. 19-27.
     
    
    (doi: 10.1002/path.6146)
    (PMID:37403270) 
     
  
  
    Sykes, R. A. et al.
  
(2023)
  
Vascular mechanisms of post-COVID-19 conditions: rho-kinase is a novel target for therapy.
    
    European Heart Journal: Cardiovascular Pharmacotherapy, 9(4),
	  pp. 371-386.
     
    
    (doi: 10.1093/ehjcvp/pvad025)
    (PMID:37019821) 
    (PMCID:PMC10236521) 
  
  
    Wood, C. S. et al.
  
(2023)
  
Spatially resolved transcriptomics deconvolutes prognostic histological subgroups in patients with colorectal cancer and synchronous liver metastases.
    
    Cancer Research, 83(8),
	  pp. 1329-1344.
     
    
    (doi: 10.1158/0008-5472.CAN-22-2794)
    (PMID:37057593) 
    (PMCID:PMC10102851) 
  
  
2022
    Fisher, N. C. et al.
  
(2022)
  
Biological misinterpretation of transcriptional signatures in tumour samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data.
    
    Clinical Cancer Research, 28(18),
	  pp. 4056-4069.
     
    
    (doi: 10.1158/1078-0432.CCR-22-1102)
    (PMID:35792866) 
    (PMCID:PMC9475248) 
  
  
    
    Nassar, Ahmad, El Zanati, Hisham, Ng, Hwei J., Khan, Khurram S.  ORCID: https://orcid.org/0000-0002-8304-5970 and Wood, Colin
  
(2022)
  
Open conversion in laparoscopic cholecystectomy and bile duct exploration: subspecialisation safely reduces the conversion rates.
    
    Surgical Endoscopy, 36(1),
	  pp. 550-558.
     
    
    (doi: 10.1007/s00464-021-08316-1)
    (PMID:33528666) 
    (PMCID:PMC8741693)
ORCID: https://orcid.org/0000-0002-8304-5970 and Wood, Colin
  
(2022)
  
Open conversion in laparoscopic cholecystectomy and bile duct exploration: subspecialisation safely reduces the conversion rates.
    
    Surgical Endoscopy, 36(1),
	  pp. 550-558.
     
    
    (doi: 10.1007/s00464-021-08316-1)
    (PMID:33528666) 
    (PMCID:PMC8741693) 
  
  
2021
    
    Nassar, Ahmad H.M., Ng, Auwei J., Ahmed, Zubir, Wysocki, Arkadiusz Peter, Wood, Colin and Abdellatif, Ayman
  
(2021)
  
Optimising the outcomes of index admission laparoscopic cholecystectomy and bile duct exploration for biliary emergencies:  a service model.
    
    Surgical Endoscopy, 35(8),
	  pp. 4192-4199.
     
    
    (doi: 10.1007/s00464-020-07900-1)
    (PMID:32860135) 
     
  
  
    
    Galbraith, Norman J.  ORCID: https://orcid.org/0000-0002-6354-6946, Wood, Colin and Steele, Colin W.
ORCID: https://orcid.org/0000-0002-6354-6946, Wood, Colin and Steele, Colin W.  ORCID: https://orcid.org/0000-0001-8518-1223
  
(2021)
  
Targeting metastatic colorectal cancer with immune oncological therapies.
    
    Cancers, 13(14),
	 
      3566.
    
    (doi: 10.3390/cancers13143566)
    (PMID:34298779) 
    (PMCID:PMC8307556)
ORCID: https://orcid.org/0000-0001-8518-1223
  
(2021)
  
Targeting metastatic colorectal cancer with immune oncological therapies.
    
    Cancers, 13(14),
	 
      3566.
    
    (doi: 10.3390/cancers13143566)
    (PMID:34298779) 
    (PMCID:PMC8307556) 
  
  
This list was generated on Thu Oct 30 17:07:27 2025 GMT.